• #ATS2018 – Ofev May Reduce Risk of Death in IPF, Has Safe Profile, Trials Show
  • Sentiments that Actually Help People with Chronic Illness Cope
  • #ERDC2018 – New EU Law to Protect Patient Data Could Affect Rare Disease Registries
  • #ATS2018 – Galapagos’ GLPG1690 Prevents Lung Function Decline in IPF Patients, Trial Shows
  • What I’ve Learned from Lung Transplant Tests
  • IPF Summit in August Aims to Close Gap Between Preclinical Data and Clinical Outcomes
  • Reclaiming Joy on Difficult Days with Pulmonary Fibrosis
  • Veracyte Launches Early Access Program for Envisia Genomic Classifier Test to Improve IPF Diagnosis
  • Pulmonary Fibrosis Foundation Adds 15 Treatment Sites to Its Care Center Network
  • Coping Strategies for When Life with IPF Gets Tough
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35